Serum Institute Permits Emergency Use of ‘Covishield’, Becomes First Indian Company
Indian vaccine manufacturer Serum Institute of India (SII) has sought formal approval for the emergency use of "Covishield", a Covid-19 vaccine from Oxford in India...